Tag Archive for: Global Cardiovascular Innovation Center

Gene Jung joins the Global Cardiovascular Innovation Center as Senior Director of Product Development

Life Science Partner recruits Senior Cardiovascular Product Development Executive.

Life Science Partner announces the recruitment of Gene Jung, formerly Vice President of Engineering at ProRhythm, to the newly created Global Cardiovascular Innovation Center (GCIC) based in Cleveland, Ohio.

Headquartered on the campus of The Cleveland Clinic, GCIC was launched with a $60 million grant for the State of Ohio to develop and commercialize new cardiovascular products.  GCIC will utilize the considerable clinical, research and commercialization capabilities of the GCIC member organizations in northeast Ohio and focus on developing technologies in partnership with established cardiovascular-focused companies and in newly-formed start-up companies.

In Jung’s most recent role at ProRhythm, he was responsible for developing the company’s High Intensity Focused Ultrasound (HIFU) technology into a commercial product for Atrial Fibrillation.

Previously, Jung was a Medical Device Consultant in Tokyo where he designed and developed intra-vascular coronary products for numerous Japanese Medical Device Companies.   Prior to his work in Japan, Jung served as Research and Development Director at the Image Guided Therapy Division at Jomed Corporation in San Diego.

“Jung has a broad view of medical device technology from early-stage physician-driven innovation though product commercialization,” noted Tom Callaway, MD, founder and president of Life Science Partner. “His extensive technical leadership background across multiple cardiovascular platforms and his strong industry and physician networks will serve GCIC well.”

Jung earned his Bachelor of Science Degree in Mechanical Engineering from the University of Arizona in Tucson, AZ.

/0 Comments/by

Shubhayu Basu to join the Global Cardiovascular Innovation Center as Director of Product Development

Life Science Partner recruits Innovative R&D Scientist.

Life Science Partner announces the recruitment of Shubhayu Basu, PhD, formerly Group Lead for New Business Ventures at Abbott Vascular, to the newly created Global Cardiovascular Innovation Center (GCIC) based in Cleveland, Ohio.

The organization was launched with a $60 million grant for the State of Ohio to develop and commercialize new cardiovascular products.  GCIC will focus on developing technologies in partnership with established cardiovascular-focused companies and in newly-formed start-up companies.

In Basu’s former role at Abbott Vascular (formerly Guidant), he was responsible for creating and implementing processes for identifying emerging technologies and various disease spaces and opportunities against the company portfolio and growth landscape.   Previously, he served as Group Lead, Research and Development, Cardiac Therapies for the company.

Prior to joining Guidant/Abbott, Basu was a Biodesign Innovation Fellow at Stanford University’s Biodesign Program in Palo Alto, CA.

“Basu will join another LSP recruit – Gene Jung – who shares his passion about new technologies and their application in patient care,” noted Tom Callaway, MD, founder and president of Life Science Partner.  “His ability to work with complex technologies to identify commercial opportunities and to oversee their development is a perfect fit for the GCIC team.”

Basu earned both his Bachelor and Masters Degree of Technology in Biochemical Engineering and Biotechnology at the Institute of Technology in New Delhi, India.  He received his PhD in Chemical Engineering at the Ohio State University in Columbus.

/0 Comments/by

Mark Low joins the Global Cardiovascular Innovation Center as Managing Director

Life Science Partner recruits Senior Leader from the Cardiovascular Medical Device Industry.

Life Science Partner announces the recruitment of Mark Low, a senior cardiovascular medical device executive, to the newly created Global Cardiovascular Innovation Center (GCIC) based in Cleveland, Ohio. 

Headquartered on the campus of The Cleveland Clinic, GCIC was launched with a $60 million grant for the State of Ohio through its Wright Center of Innovation program to develop and commercialize new cardiovascular products.  Working with the GCIC’s Board of Directors and Commercialization Advisory Board, Low will build a team to utilize the considerable clinical, research and commercialization capabilities of the GCIC member organizations in northeast Ohio.

GCIC will be focused on developing technologies in partnership with established cardiovascular-focused companies and in newly-formed start-up companies.

Low has spent most of his career developing new cardiovascular technologies in both small, venture-backed companies and large medical device companies.   He has most recently provided market analysis, strategy and business development services for cardiovascular applications and technologies as an independent consultant.  Previously, Low was Vice President of Business and Market Development for Sonus Pharmaceuticals, Inc., a drug delivery and specialty pharmaceutical company in Bothell, Washington.  Earlier he led the market development of intra-vascular ultrasound (IVUS) at Hewlett Packard.

“Low is a well-networked and experienced marketing and commercialization executive in the field of cardiovascular technologies,” noted Tom Callaway, MD, founder and president of Life Science Partner.  “Working with GCIC and its affiliate institutions, Low will connect technology leaders at Cleveland Clinic and Case Western with corporate leaders and venture funding sources.”

Low earned a Bachelor of Arts in Natural Science from Johns Hopkins University, a Master of Science in Physiology from the Medical College of Wisconsin, and a Master of Science in Technical Communication from Rensselaer Polytechnic Institute.

/0 Comments/by